12/4
10:58 am
tem
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
12/1
06:03 pm
tem
Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.
Low
Report
Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.
12/1
05:37 am
tem
Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]
Medium
Report
Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]
11/25
07:19 am
tem
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/18
08:30 am
tem
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/15
11:51 pm
tem
Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat [Yahoo! Finance]
Medium
Report
Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat [Yahoo! Finance]
11/15
10:01 am
tem
Tempus AI: Opportunity To Build Position [Seeking Alpha]
Medium
Report
Tempus AI: Opportunity To Build Position [Seeking Alpha]
11/14
08:48 am
tem
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research [Yahoo! Finance]
Low
Report
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research [Yahoo! Finance]
11/14
08:30 am
tem
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
Medium
Report
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
11/12
05:37 pm
tem
Tempus AI: A Good Bet For The Future Of Health Care [Seeking Alpha]
Medium
Report
Tempus AI: A Good Bet For The Future Of Health Care [Seeking Alpha]
11/11
12:21 pm
tem
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at Morgan Stanley from $68.00 to $80.00. They now have an "overweight" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at Morgan Stanley from $68.00 to $80.00. They now have an "overweight" rating on the stock.
11/11
12:21 pm
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Piper Sandler from $105.00 to $80.00. They now have a "neutral" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Piper Sandler from $105.00 to $80.00. They now have a "neutral" rating on the stock.
11/7
08:07 am
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at HC Wainwright from $98.00 to $89.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at HC Wainwright from $98.00 to $89.00. They now have a "buy" rating on the stock.
11/5
08:30 am
tem
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
Low
Report
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
11/5
08:08 am
tem
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $96.00 price target on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $96.00 price target on the stock.
11/5
08:07 am
tem
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at Needham & Company LLC from $70.00 to $100.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at Needham & Company LLC from $70.00 to $100.00. They now have a "buy" rating on the stock.
11/5
04:03 am
tem
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/4
08:11 pm
tem
Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Medium
Report
Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
11/4
04:01 pm
tem
Tempus Reports Third Quarter 2025 Results
Low
Report
Tempus Reports Third Quarter 2025 Results
10/28
08:30 am
tem
Tempus to Participate in the Stifel 2025 Healthcare Conference
Medium
Report
Tempus to Participate in the Stifel 2025 Healthcare Conference
10/25
12:13 pm
tem
Tempus AI (NASDAQ:TEM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tempus AI (NASDAQ:TEM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/22
12:24 pm
tem
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Canaccord Genuity Group Inc. to a "strong-buy" rating.
Low
Report
Tempus AI (NASDAQ:TEM) was upgraded by analysts at Canaccord Genuity Group Inc. to a "strong-buy" rating.
10/22
10:01 am
tem
Tempus AI (NASDAQ:TEM) was given a new $105.00 price target on by analysts at Piper Sandler.
Medium
Report
Tempus AI (NASDAQ:TEM) was given a new $105.00 price target on by analysts at Piper Sandler.
10/22
08:34 am
tem
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at BTIG Research from $85.00 to $96.00. They now have a "buy" rating on the stock.
Medium
Report
Tempus AI (NASDAQ:TEM) had its price target raised by analysts at BTIG Research from $85.00 to $96.00. They now have a "buy" rating on the stock.
10/21
08:30 am
tem
Tempus to Report Third Quarter 2025 Financial Results on November 4
Low
Report
Tempus to Report Third Quarter 2025 Financial Results on November 4